Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma

Joo Hyun Kim(Yonsei University), Chaehwa Park(Samsung (South Korea))
BMC Cancer
October 10, 2019
Cited by 51


Related Papers